Verastem Inc (NASDAQ:VSTM)
| 1.20 Delayed Data As of Aug 05 |  +0.07 / +6.19%Today’s Change | 1.00 Today|||52-Week Range 3.58 | -41.46% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $222.7M |
Company Description
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
Contact Information
Verastem, Inc. 117 Kendrick Street Needham Massachusetts 02494 |
Employees
Shareholders
| Other institutional | 48.23% |
| Individual stakeholders | 28.75% |
| Mutual fund holders | 13.53% |
Top Executives
| Brian M. Stuglik | Chief Executive Officer & Director |
| Dan Paterson | President & Chief Operating Officer |
| Robert E. Gagnon | Chief Financial & Business Officer |
| Jonathan Pachter | Chief Scientific Officer |
| Louis J. Denis | Chief Medical Officer |
